1.O’Keefe JH, Bhatti SK, Bajwa A, DiNicolantonio JJ, Lavie CJ. Alcohol and cardiovascular health: the dose makes the poison…or the remedy. Mayo Clin Proc. 2014;89(3):382–93.
2.Zhang C, Qin YY, Chen Q, Jiang H, Chen XZ, Xu CL, et al. Alcohol intake and risk of stroke: a dose-response meta-analysis of prospective studies. Int J Cardiol. 2014;174(3):669–77.
3.Lin Y, Kikuchi S, Tamakoshi A, Wakai K, Kawamura T, Iso H, et al. Alcohol consumption and mortality among middle-aged and elderly Japanese men and women. Ann Epidemiol. 2005;15(8):590–7.
4.Bell S, Daskalopoulou M, Rapsomaniki E, George J, Britton A, Bobak M, et al. Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records. BMJ. 2017;356:j909.
5.Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA, Stampfer MJ, Willett WC, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med. 2003;348(2):109–18.
6.Goldberg IJ. To drink or not to drink? N Engl J Med. 2003;348(2):163–4.
7.Kloner RA, Rezkalla SH. To drink or not to drink? That is the question. Circulation. 2007;116(11):1306–17.
8.Collaborators GA. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018.
9.Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.
10.Brownell KD, Warner KE. The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? Milbank Q. 2009;87(1):259–94.
11.Macdonald I. Nonsense and non-science in nutrition. Proc Nutr Soc. 1983;42(3):513–23.
12.Grønbaek M. Alcohol consumption and mortality. Type of drink has been shown to matter. BMJ. 1999;319(7219):1267–8.
13.Grønbaek M. Factors influencing the relation between alcohol and cardiovascular disease. Curr Opin Lipidol. 2006;17(1):17–21.
14.Mann CJ. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J. 2003;20(1):54–60.
15.Hernán MA, Hernández-Díaz S, Werler MM, Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol. 2002;155(2):176–84.
16.Hernán MA, Robins JM. Estimating causal effects from epidemiological data. J Epidemiol Community Health. 2006;60(7):578–86.
17.Greenland S. Randomization, statistics, and causal inference. Epidemiology. 1990;1(6):421–9.
18.VanderWeele TJ, Ding P. Sensitivity Analysis in Observational Research: Introducing the E-Value. Ann Intern Med. 2017;167(4):268–74.
19.Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction. 2000;95(10):1505–23.
20.Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014;12:182.
21.Naimi TS, Brown DW, Brewer RD, Giles WH, Mensah G, Serdula MK, et al. Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults. Am J Prev Med. 2005;28(4):369–73.
22.Iqbal SA, Wallach JD, Khoury MJ, Schully SD, Ioannidis JP. Reproducible research practices and transparency across the biomedical literature. PLoS biology. 2016;14(1):e1002333.
23.Wallach J, Egilman A, Gopal A, Swami N, Krumholz H, Ross J. Biomedical journal speed and efficiency: a cross-sectional pilot survey of author experiences. Research Integrity and Peer Review. 2018;3(1).
24.Wallach JD, Boyack KW, Ioannidis JPA. Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017. PLoS Biol. 2018;16(11):e2006930.
25.Hemkens LG, Ewald H, Naudet F, Ladanie A, Shaw JG, Sajeev G, et al. Interpretation of epidemiologic studies very often lacked adequate consideration of confounding. J Clin Epidemiol. 2018;93:94–102.
26.Serghiou S, Patel CJ, Tan YY, Koay P, Ioannidis JP. Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications. J Clin Epidemiol. 2016;71:58–67.
27.Poikolainen K, Vahtera J, Virtanen M, Linna A, Kivimäki M. Alcohol and coronary heart disease risk—is there an unknown confounder? Addiction. 2005;100(8):1150–7.
28.Rehm J, Shield KD. The impact of confounding and alcohol consumption patterns on the calculated risks of alcohol-related diseases. Addiction. 2013;108(9):1544–5.
29.Grønbaek M, Deis A, Sørensen TI, Becker U, Borch-Johnsen K, Müller C, et al. Influence of sex, age, body mass index, and smoking on alcohol intake and mortality. BMJ. 1994;308(6924):302–6.
30.Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction. 2012;107(7):1246–60.
31.Chikritzhs T, Fillmore K, Stockwell T. A healthy dose of scepticism: four good reasons to think again about protective effects of alcohol on coronary heart disease. Drug Alcohol Rev. 2009;28(4):441–4.
32.Müllner M, Matthews H, Altman DG. Reporting on statistical methods to adjust for confounding: a cross-sectional survey. Ann Intern Med. 2002;136(2):122–6.
33.Groenwold RH, Van Deursen AM, Hoes AW, Hak E. Poor quality of reporting confounding bias in observational intervention studies: a systematic review. Ann Epidemiol. 2008;18(10):746–51.
34.Groenwold RH, Klungel OH, Altman DG, van der Graaf Y, Hoes AW, Moons KG, et al. Adjustment for continuous confounders: an example of how to prevent residual confounding. CMAJ. 2013;185(5):401–6.
35.Patel CJ, Burford B, Ioannidis JP. Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations. J Clin Epidemiol. 2015;68(9):1046–58.
36.Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.
37.Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JPA, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses. Alzheimers Dement. 2017;13(4):406–18.
38.Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607.
39.Bortolato B, Köhler CA, Evangelou E, León-Caballero J, Solmi M, Stubbs B, et al. Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses. Bipolar Disord. 2017;19(2):84–96.
40.McRae MP. Health Benefits of Dietary Whole Grains: An Umbrella Review of Meta-analyses. J Chiropr Med. 2017;16(1):10–8.
41.Neuenschwander M, Ballon A, Weber KS, Norat T, Aune D, Schwingshackl L, et al. Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ. 2019;366:l2368.
42.Pouwels KB, Widyakusuma NN, Groenwold RH, Hak E. Quality of reporting of confounding remained suboptimal after the STROBE guideline. J Clin Epidemiol. 2016;69:217–24.